|
Status |
Public on Jul 31, 2021 |
Title |
Stem cell fate choices are regulated through antagonistic control of lysosomes by MYC and TFEB [RNA-Seq 5] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
We show that lysosomes are antagonistically controlled by TFEB and MYC to balance catabolic and anabolic processes required for activating LT-HSC and guiding their lineage fate. TFEB-mediated induction of the endolysosomal pathway for membrane receptor degradation limits LT-HSC metabolic and mitogenic activation; this promotes quiescence and self-renewal and governs erythroid-myeloid commitment. By contrast, MYC engages biosynthetic processes while repressing lysosomal catabolism to drive LT-HSC activation. Collectively, our study identifies lysosomes as a central regulatory hub for proper and coordinated stem cell fate determination.
|
|
|
Overall design |
Short-term hematopoietic stem cells (ST-HSC) were sorted from human cord blood and cultured overnight before transduction with lentivirus to overexpress GP91 (CTRL) or TFEB. Three days later, BFP+ transduced cells were sorted for RNA extraction and sequencing. Authors state that raw data will be uploaded to the EGA database.
|
|
|
Contributor(s) |
Garcia-Prat L |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Jul 07, 2020 |
Last update date |
Jul 31, 2021 |
Contact name |
Laura Garcia Prat |
E-mail(s) |
laura.garciaprat@uhnresearch.ca
|
Organization name |
University Health Network
|
Department |
Princess Margaret Cancer Centre
|
Street address |
101 College street
|
City |
Toronto |
ZIP/Postal code |
M5G 1L7 |
Country |
Canada |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (4)
|
|
This SubSeries is part of SuperSeries: |
GSE153917 |
Stem cell fate choices are regulated through antagonistic control of lysosomes by MYC and TFEB |
|
Relations |
BioProject |
PRJNA644531 |